Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
Phase 3
Completed
- Conditions
- Opioid-Related Disorders
- Registration Number
- NCT00078130
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 223
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Opiate abstinence
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
Mercy Hospital
🇺🇸Portland, Maine, United States
Mountain Manor
🇺🇸Baltimore, Maryland, United States
ASAP
🇺🇸Albuquerque, New Mexico, United States
Duke Addictions Program
🇺🇸Durham, North Carolina, United States
Mercy Hospital🇺🇸Portland, Maine, United States